Maryland State Retirement & Pension System lifted its holdings in Molina Healthcare, Inc (NYSE:MOH – Free Report) by 283.5% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 10,163 shares of the company’s stock after purchasing an additional 7,513 shares during the period. Maryland State Retirement & Pension System’s holdings in Molina Healthcare were worth $1,355,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Baird Financial Group Inc. bought a new position in Molina Healthcare in the first quarter worth approximately $210,000. NewEdge Advisors LLC lifted its holdings in Molina Healthcare by 33.4% during the first quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock worth $364,000 after buying an additional 277 shares during the period. Jones Financial Companies Lllp boosted its position in Molina Healthcare by 713.3% during the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock valued at $544,000 after acquiring an additional 1,448 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Molina Healthcare by 19.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company’s stock valued at $82,172,000 after acquiring an additional 40,531 shares in the last quarter. Finally, Woodline Partners LP purchased a new position in shares of Molina Healthcare in the 1st quarter valued at $1,541,000. 98.50% of the stock is currently owned by institutional investors.
Molina Healthcare Stock Down 3.4%
Shares of MOH stock opened at $233.44 on Thursday. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $244.89. The stock’s fifty day moving average price is $201.97 and its 200 day moving average price is $174.74. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The company has a market cap of $12.16 billion, a price-to-earnings ratio of 69.07 and a beta of 0.74.
Insider Activity
In related news, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the transaction, the insider directly owned 67,175 shares of the company’s stock, valued at $12,502,611. This trade represents a 20.96% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.44% of the company’s stock.
Analyst Ratings Changes
MOH has been the subject of several recent research reports. Cantor Fitzgerald boosted their price target on Molina Healthcare from $144.00 to $209.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Bank of America upgraded Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price on the stock in a research note on Wednesday, April 29th. TD Cowen boosted their target price on shares of Molina Healthcare from $163.00 to $230.00 and gave the stock a “hold” rating in a report on Tuesday. Barclays decreased their price target on shares of Molina Healthcare from $199.00 to $184.00 and set an “underweight” rating for the company in a research report on Wednesday, July 8th. Finally, Truist Financial raised their price target on shares of Molina Healthcare from $205.00 to $250.00 and gave the company a “hold” rating in a report on Tuesday. Three research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $207.06.
Get Our Latest Report on Molina Healthcare
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Featured Articles
- Five stocks we like better than Molina Healthcare
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
